Related Experiment Videos
Shooting for PARs in lung diseases.
James D Moffatt1, Clive P Page, Geoffrey J Laurent
1Sackler Institute of Pulmonary Pharmacology, GKT School of Biomedical Sciences, Guy's Campus, King's College London, London SE1 1UL, UK.
Current Opinion in Pharmacology
|May 14, 2004
Summary
Proteinase-activated receptors (PARs) are crucial in lung diseases. Further research is needed to understand PAR functions in the lungs for potential drug development.
Area of Science:
- Immunology
- Pharmacology
- Cell Biology
Background:
- Proteinase-activated receptors (PARs) are G-protein-coupled receptors activated by proteases.
- PARs are expressed in airway cells and implicated in inflammatory lung diseases.
- PAR activation may contribute to pathological changes in the lungs.
Purpose of the Study:
- To highlight the role of PARs in lung diseases.
- To emphasize the need for further research into PAR functions in the lung.
Main Methods:
- Review of existing in vitro studies.
- Analysis of current pharmacological tools.
Main Results:
- PARs are present in various airway cell types relevant to lung inflammation.
- PAR activation is linked to pathological changes in lung diseases.
Conclusions:
- PARs represent promising therapeutic targets for lung diseases.
- More in vivo research is required to fully establish PARs as drug targets due to limitations in current data and tools.